A Reference Range for Thromboelastographic Parameters in Uncomplicated Pregnancy. Helena Maybury 1, Patricia Squire 1, Elysee Hille 2, Frank Pierik 2,

Slides:



Advertisements
Similar presentations
Generation R Study Claudia Kruithof, MSc datamanager Generation R EUCCONET workshop june 2011 – Record Linkage.
Advertisements

Diabetes in pregnancy Dr Than Than Yin.
The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.
Audit of pregnancy for women with pre-existing diabetes attending the maternal medicine clinic at St. Michael’s Hospital in 2002.
Thromboelastography to predict the safe removal of epidural catheters following elective Caesarean section Smith R 1, Sharpe P 2, Waugh JJS 3 1 Medical.
Thromboelastography as an Adjunct Tool to Assess Coagulation Disturbances in Isolated Traumatic Brain Injury Patients Asaph Nini MD 1, David Livingstone.
THE EFFECT OF MATERNAL OBESITY AND GESTATIONAL WEIGHT GAIN ON OBSTETRIC OUTCOMES CN Khairun 1,3, I Nazimah 2, Tham Seng Woh 1 N Norzilawati 3 AM Mohd Rizal.
The ACOG Task force on hypertension in pregnancy
VITAMIN D AND MATERNAL HEALTH Studies linking vitamin D with maternal complications Claire K. Candelier The Midland Hotel, Manchester 17 th September 2013.
Dr. Y. Shah MD, Associate Dean of Global Health, DMU Lindsay Zylstra, Central College.
Chapter 14 Nutrition during Pregnancy and Lactation.
Prenatal Care ..
Reproductive Health Indicators for Asian Women in Massachusetts Susan E. Manning, MD, MPH CDC Maternal and Child Health Epidemiology Assignee Massachusetts.
NuPAFP Conference October 13-14, 2010 Color Me Healthy Gestational Weight Gain Paula Garrett, MS, RD.
Pregnancy Outcome Prediction Study University Department of Obstetrics and Gynaecology; PI – Professor Gordon CS Smith BACKGROUND The current pattern of.
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
Factors associated with perinatal deaths in women delivering in a health facility in Malawi Lily C. Kumbani, Johanne Sundby and Jon Øyvind Odland.
Underweight pregnant women in low risk populations: Does a low BMI (
報 告 者 王瓊琦. postpartum depression : identification of women at risk.
TEMPLATE DESIGN © Maternal and fetal outcomes in women with chronic kidney disease M Kalidindi, S Marlene, K Bennett-Richards,
M.G.S.D. The Gestational Diabetes Study in the Mediterranean Region Protocol C. Savona-Ventura Research Management Committee – M.G.S.D.
Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.
Birth Certificate data is crucial for medical research.
The use of thromboelastography to assess haemostatic changes in post-partum women. HJ MAYBURY, AS GORNALL, *JJ KURINCZUK, JC KONJE, **S PAVORD, JJ WAUGH.
TEMPLATE DESIGN © Evaluation of the antenatal care and obstetric outcome of obese pregnant women and those with a healthy.
Ealing Hospital NHS Trust The path from external cephalic version to vaginal delivery – how many does it take? T AN T OH L ICK 1, I LKA T AN 2, P AOLA.
Chapter 4. video XJ5md2iwhttps:// XJ5md2iw.
TEMPLATE DESIGN © Maternal Obesity & Obstetric outcomes John R, Johnson JK, Pavey J Department of Obstetrics and Gynaecology,
Title: Effect of prenatal care in pregnancy and delivery method Beigi.M, Afghari.A, Javanmardi.Z MSc, Department of midwifery,School of Nursing & Midwifery,
THE STRUCTURE OF THE TRAINING SESSION  1. Introduction  2. The theoretical part  3. The practical part  - Supervision of patients  - Algorithm skills.
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
HIGHER HUMAN BIOLOGY Unit 2 Physiology and Health 1. Ante-natal Screening.
Alcohol Guidelines Revised UK CMO Guidelines A single guideline for men and women: this will now be 14 units a week for both men and women A recommendation.
Stillbirth in twins, exploring the optimal gestational age for delivery: a retrospective cohort study S Wood, S Tang, S Ross, R Sauve.
TEMPLATE DESIGN © Backgroud Methods ResultsConclusions References OPTIONAL LOGO HERE 1.Heslehurst N, Rankin J, Wilkinson.
Thromboelastography shows Thromboprophylaxis following Caesarean Section need not be continued after 5 days for women at Moderate Risk of Thromboembolism.
 Prolonged pregnancy  Decreased fetal movements  Hypertension in pregnancy  Diabetes in pregnancy  Fetal growth restriction  Multiple gestation.
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Timalsina U, Sharma S, Giri S, Basyal B, Bhandari S, Neupane M
Risk factors for maternal anaemia and low birth weight in pregnant women living in rural India: a prospective cohort study  A.S. Ahankari, P.R. Myles,
Inonu University, Turgut Ozal Medical Centre
Risk Factors Preeclampsia in previous pregnancies
Hypothyroidism during pregnancy
Vital statistics in obstetrics.
Preterm birth < 37 weeks
Antenatal clinic,a missed opportunity for hypertension education??
HYPERTENSIVE DISORDERS OF PREGNANCY
Defining hypertension
The impact of ethnicity on presentation to antenatal care among pregnant women living with HIV in the UK and Ireland.
PLASMA HOMOCYSTEINE LEVELS AS A PREDICTOR
Development of Indicator Scores Using Items from the WHO Safe Motherhood Needs Assessment to Examine Utilisation of Maternal Health Services in South Africa.
A. Khan, V. R. N. Ramoutar, B. Bassaw
Maternal health and early years
Shortened Coagulation profile in Pregnancy - A Comparative analysis in different trimesters: Retrospective study from a tertiary care centre Bhavika Rishi,
Investigation of early prognostic factors in the development of early onset preeclampsia Nilay Karaca MD.
Pregnancy in Primary Sclerosing Cholangitis
Breakout Group 1.
Anna David Reader in Obstetrics and Maternal Fetal Medicine
Fellowship of infertility
Modeling the Causal Effects of Assisted Reproductive Technology (ART)
Hypertension in Pregnancy NICE Guidelines
Obstetric Cholestasis (lntrahepatic cholestasis of pregnancy):
Small steps to a healthy pregnancy
DEFINITIONS : QUICK REVIEW
Risk Factors for Adverse Birth Outcomes
Nat. Rev. Nephrol. doi: /nrneph
S1 Table: Inclusion/Exclusion criteria
Lesson Starter List 3 things that are of risk to a growing baby and explain why they are a risk.
The Preterm Birth Clinic Wellbeing Study
Presentation transcript:

A Reference Range for Thromboelastographic Parameters in Uncomplicated Pregnancy. Helena Maybury 1, Patricia Squire 1, Elysee Hille 2, Frank Pierik 2, David Taylor 1, Sue Pavord 3, Jason Waugh Reproductive Sciences Section, Department of CSMM, University of Leicester, Leicester, LE2 7LX, UK 2. TNO Quality of Life, JPB, PO Box 2215, 2301 CE Leiden, Netherlands 3. Department of Haematology, Leicester Royal Infirmary, Leicester, LE1 5WW, UK Introduction. Pregnancy is a hypercoagulable state associated with increased levels of procoagulant factors, enhanced thrombin generation and impaired fibrinolysis. Our current knowledge is based upon the changing levels of individual clotting and fibrinolytic factors. It has long been hypothesised that an exaggeration of the normal physiological adaptation of the haemostatic system in pregnancy is linked to thromboembolic disease, pre-eclampsia and intra-uterine growth retardation. Objective. To define gestation specific reference ranges for 5 thromboelastographic (TEG) parameters in uncomplicated pregnancy. Methods. In this prospective cross-sectional study a citrated blood sample was obtained from 260 low risk pregnant women attending Leicester Royal Infirmary for antenatal care and analysed by thromboelastography. Antenatal notes and delivery outcomes were reviewed and only those women with uncomplicated pregnancies were included. 37 women were excluded, 11 with gestational hypertension, 8 with pre-eclampsia, 4 with preterm birth and 14 with birthweight <10 th centile. A control group of 108 non-pregnant women were sampled. This group was less than 40 years of age, not taking hormonal contraception or regular prescription medication and all of whom had previous normal pregnancies and birth outcomes. Technique. Thromboelastography is a tool that enables the global assessment of blood clotting to be made from a single blood sample. A graphic presentation of 5 parameters is produced which represents different components of clot formation and stabilisation. R time (reaction time) is the latency time from placing the blood in the cup until the clot starts to form, time taken to initialise clot formation K time is arbitrarily assigned as the time between the TEG trace reaching 2mm and going up to 20mm α angle is the slope drawn from the R to K value and represents velocity of clot formation. MA (maximum amplitude) is the greatest vertical amplitude of the TEG trace and represents the strength of the clot. Coagulation Index is derived from the above parameters to reflect overall coagulation. Conclusion: Thromboelastography demonstrates that by the first trimester pregnant women are significantly more hypercoagulable than non-pregnant controls and the hypercoagulable state increases as pregnancy progresses. In the first and second trimesters the time taken to initialise clot formation (R time) is dramatically reduced. The most significant increase in strength of clot (MA) occurs in the 3 rd trimester. We hypothesise that these changes reflect the physiological processes of pregnancy, rapid formation of small clots at implantation and an increase in clot stability as the challenge of parturition approaches. The definition of a reference range is essential to explore the future use of thromboelastography in the identification and management of high-risk pregnancy. p< p<0.005 p< p=0.001 p=0.005 p<0.05 p< p=0.001